Physical, physiological demands and movement profiles of elite men’s field hockey games

The aim of this study was to investigate physical demands, physiological demands, and movement profiles of different positions across four quarters in professional men’s field hockey games. Eighteen professional male field hockey players participated in the study, and data were collected in eleven official matches. Players wore global positioning system units and heart rate monitors to collect physical, physiological, and movement profile data. Defenders had significantly higher absolute total distance covered, player load, acceleration and deceleration count, and forward-backward initial movement analysis (IMA) count, but lower high speed running distance, compared with midfielders and forwards (p<.05). However, when using relative metrics (normalised by playing time), defenders had the lowest physical and physiological outputs, and forwards had the highest (p<.05). Total distance covered per minute, high-speed running distance per minute, player load per minute, acceleration and deceleration count per minute, and repeated high-intensity efforts per minute were all significantly higher in quarter 1 than in other three quarters (p<.05). The percentages of linear running and non-linear dynamic movement duration decreased quarter by quarter. Modified training impulse per minute reached its peak in quarter 2 (p<.05). It was concluded that defenders had the highest volume in terms of the game demands due to their high playing minutes; however, they had the lowest relative volume compared with the other two positions. Forwards had the highest linear running intensity, while midfielders were required to perform more multi-directional, non-linear movements. Quarter 1 was the most active quarter and players became fatigued in quarter 2. IMA counts were not sensitive to fatigue compared to movement profile and modified training impulse variables

El impacto del turismo el países subdesarrollados

El turismo es uno de los sectores más potentes para un país desarrollado y aporta numerosos beneficios. Sin embargo, para un país subdesarrollado supone una gran potencialidad para su economía y sociedad. El objetivo de este Trabajo de Fin de Grado es, mediante una investigación previa, realizar un análisis del impacto del turismo en los países subdesarrollados, utilizando ejemplos del mundo. Para abordar esta temática, se lleva a cabo un estudio en la conceptualización y la revisión de la literatura existente, que se ampliará con información proveniente de organizaciones de renombre y proyectos actuales. De esta manera, se podrán analizar los efectos de este sector en diversos ámbitos: económico, cultural, medioambiental, etc. A través de este proyecto se examina el tipo de dificultades y retos a los que se tienen que enfrentar los países, objeto de estudio, así como el tipo de oportunidades que se pueden generar. También se considera la importancia de la gestión y planificación sostenible del turismo, destacando la necesidad de estrategias y políticas que promuevan un turismo responsable. Por último, se estudia el turismo pro-pobre, cuyo objetivo es maximizar beneficios para las comunidades locales y lograr la inversión en la preservación de recursos.Grado en Turism

Alcohol Promotes Mammary Tumor Growth through Activation of VEGF-Dependent Tumor Angiogenesis

Alcohol consumption has been recognized as a risk factor for breast cancer. Experimental studies demonstrate that alcohol exposure promotes the progression of existing mammary tumors. However, the mechanisms underlying this effect remain unclear. In the present study, the role of vascular endothelial growth factor (VEGF) in alcohol promotion of breast cancer development was investigated using a mouse xenograft model of mammary tumors and a three-dimensional (3D) tumor/endothelial cell co-culture system. For the mouse xenograft model, mouse E0771 breast cancer cells were implanted into the mammary fat pad of C57BL6 mice. These mice were exposed to alcohol in their drinking water. For the 3D co-culture system, E0771 cells and MDA-MB231 breast cancer cells were co-cultured with SVEC4-10EE2 and human umbilical vein endothelial cells, respectively. The results demonstrated that alcohol increased tumor angiogenesis and accelerated tumor growth. Furthermore, it appeared that alcohol induced VEGF expression in breast cancer cells in vitro and in vivo. Blocking VEGF signaling by SU5416 inhibited tumor angiogenesis in the 3D tumor/endothelial cell co-culture system. Furthermore, injection of SU5416 into mice inhibited alcohol-promoted mammary tumor growth in vivo. These results indicate that alcohol may promote mammary tumor growth by stimulating VEGF-dependent angiogenesis

Mapping the Galactic disk with the LAMOST and Gaia Red clump sample: I: precise distances, masses, ages and 3D velocities of ∼\sim 140000 red clump stars

We present a sample of $\sim$ 140,000 primary red clump (RC) stars of spectral signal-to-noise ratios higher than 20 from the LAMOST Galactic spectroscopic surveys, selected based on their positions in the metallicity-dependent effective temperature--surface gravity and color--metallicity diagrams, supervised by high-quality $Kepler$ asteroseismology data. The stellar masses and ages of those stars are further determined from the LAMOST spectra, using the Kernel Principal Component Analysis method, trained with thousands of RCs in the LAMOST-$Kepler$ fields with accurate asteroseismic mass measurements. The purity and completeness of our primary RC sample are generally higher than 80 per cent. For the mass and age, a variety of tests show typical uncertainties of 15 and 30 per cent, respectively. Using over ten thousand primary RCs with accurate distance measurements from the parallaxes of Gaia DR2, we re-calibrate the $K_{\rm s}$ absolute magnitudes of primary RCs by, for the first time, considering both the metallicity and age dependencies. With the the new calibration, distances are derived for all the primary RCs, with a typical uncertainty of 5--10 per cent, even better than the values yielded by the Gaia parallax measurements for stars beyond 3--4 kpc. The sample covers a significant volume of the Galactic disk of $4 \leq R \leq 16$ kpc, $|Z| \leq 5$ kpc, and $-20 \leq \phi \leq 50^{\circ}$. Stellar atmospheric parameters, line-of-sight velocities and elemental abundances derived from the LAMOST spectra and proper motions of Gaia DR2 are also provided for the sample stars. Finally, the selection function of the sample is carefully evaluated in the color-magnitude plane for different sky areas. The sample is publicly available.Comment: 16 pages, 19 figures, 3 tables, accepted for publication in ApJ

The proper class generated by weak supplements

We show that, for hereditary rings, the smallest proper classes containing respectively the classes of short exact sequences determined by small submodules, submodules that have supplements and weak supplement submodules coincide. Moreover, we show that this class can be obtained as a natural extension of the class determined by small submodules. We also study injective, projective, coinjective and coprojective objects of this class. We prove that it is coinjectively generated and its global dimension is at most 1. Finally, we describe this class for Dedekind domains in terms of supplement submodules.TUBITAK (107T709

Fetal Brain Tissue Annotation and Segmentation Challenge Results

In-utero fetal MRI is emerging as an important tool in the diagnosis and analysis of the developing human brain. Automatic segmentation of the developing fetal brain is a vital step in the quantitative analysis of prenatal neurodevelopment both in the research and clinical context. However, manual segmentation of cerebral structures is time-consuming and prone to error and inter-observer variability. Therefore, we organized the Fetal Tissue Annotation (FeTA) Challenge in 2021 in order to encourage the development of automatic segmentation algorithms on an international level. The challenge utilized FeTA Dataset, an open dataset of fetal brain MRI reconstructions segmented into seven different tissues (external cerebrospinal fluid, grey matter, white matter, ventricles, cerebellum, brainstem, deep grey matter). 20 international teams participated in this challenge, submitting a total of 21 algorithms for evaluation. In this paper, we provide a detailed analysis of the results from both a technical and clinical perspective. All participants relied on deep learning methods, mainly U-Nets, with some variability present in the network architecture, optimization, and image pre- and post-processing. The majority of teams used existing medical imaging deep learning frameworks. The main differences between the submissions were the fine tuning done during training, and the specific pre- and post-processing steps performed. The challenge results showed that almost all submissions performed similarly. Four of the top five teams used ensemble learning methods. However, one team's algorithm performed significantly superior to the other submissions, and consisted of an asymmetrical U-Net network architecture. This paper provides a first of its kind benchmark for future automatic multi-tissue segmentation algorithms for the developing human brain in utero.Comment: Results from FeTA Challenge 2021, held at MICCAI; Manuscript submitte

Robust estimation of bacterial cell count from optical density

Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals &lt;1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570